Perotti D, OSullivan M, Walz A, Davick J, Al-Saadi R, Benedetti D
Nat Rev Urol. 2025; .
PMID: 39881003
DOI: 10.1038/s41585-024-00993-6.
Cyrta J, Masliah-Planchon J, Hoare O, Brillet R, Andrianteranagna M, Sohier P
J Pathol. 2025; 265(3):357-371.
PMID: 39853675
PMC: 11794973.
DOI: 10.1002/path.6390.
Liapodimitri A, Tetens A, Craig-Schwartz J, Lunsford K, Skalitzky K, Koldobskiy M
Cancers (Basel). 2025; 16(24.
PMID: 39766049
PMC: 11674401.
DOI: 10.3390/cancers16244149.
Kes M, Morales-Rodriguez F, Zaal E, de Souza T, Proost N, van de Ven M
Cell Rep Med. 2024; 6(1):101878.
PMID: 39708810
PMC: 11866552.
DOI: 10.1016/j.xcrm.2024.101878.
Merk D, Tsiami F, Hirsch S, Walter B, Haeusser L, Maile J
Genome Biol. 2024; 25(1):301.
PMID: 39617889
PMC: 11610224.
DOI: 10.1186/s13059-024-03438-w.
The Biological Clock of Liver Metabolism in Metabolic Dysfunction-Associated Steatohepatitis Progression to Hepatocellular Carcinoma.
Rajan P, Udoh U, Finley R, Pierre S, Sanabria J
Biomedicines. 2024; 12(9).
PMID: 39335475
PMC: 11428469.
DOI: 10.3390/biomedicines12091961.
Constitutional mosaicism of pathogenic variants in SMARCB1 in a subset of patients with sporadic rhabdoid tumors.
Fleischmann L, Nemes K, Glaser S, Kouroukli A, Boros M, Bens S
Neuro Oncol. 2024; 27(2):533-544.
PMID: 39288268
PMC: 11812048.
DOI: 10.1093/neuonc/noae188.
PHF6 cooperates with SWI/SNF complexes to facilitate transcriptional progression.
Mittal P, Myers J, Carter R, Radko-Juettner S, Malone H, Rosikiewicz W
Nat Commun. 2024; 15(1):7303.
PMID: 39181868
PMC: 11344777.
DOI: 10.1038/s41467-024-51566-5.
Chromatin remodellers as therapeutic targets.
Malone H, Roberts C
Nat Rev Drug Discov. 2024; 23(9):661-681.
PMID: 39014081
PMC: 11534152.
DOI: 10.1038/s41573-024-00978-5.
A kinome drug screen identifies multi-TKI synergies and ERBB2 signaling as a therapeutic vulnerability in MYC/TYR subgroup atypical teratoid rhabdoid tumors.
Golbourn B, Ho B, Bondoc A, Luck A, Fan X, Richardson E
Neuro Oncol. 2024; 26(10):1895-1911.
PMID: 38981018
PMC: 11448967.
DOI: 10.1093/neuonc/noae120.
SMARCB1 Gene Therapy Using a Novel Tumor-Targeted Nanomedicine Enhances Anti-Cancer Efficacy in a Mouse Model of Atypical Teratoid Rhabdoid Tumors.
Kim S, Moghe M, Rait A, Donaldson K, Harford J, Chang E
Int J Nanomedicine. 2024; 19:5973-5993.
PMID: 38895149
PMC: 11185260.
DOI: 10.2147/IJN.S458323.
Lineage-Selective Dependencies in Pediatric Cancers.
Ritter K, Durbin A
Cold Spring Harb Perspect Med. 2024; .
PMID: 38806246
PMC: 11882016.
DOI: 10.1101/cshperspect.a041573.
Developmental origins shape the paediatric cancer genome.
Chen X, Yang W, Roberts C, Zhang J
Nat Rev Cancer. 2024; 24(6):382-398.
PMID: 38698126
PMC: 11571274.
DOI: 10.1038/s41568-024-00684-9.
Central nervous system embryonal tumors with EWSR1-PLAGL1 rearrangements reclassified as INI-1 deficient tumors at relapse.
Bielamowicz K, Littrell M, Albert G, Parker L, Jayappa S, Aldape K
J Neurooncol. 2024; 168(2):367-373.
PMID: 38639853
PMC: 11147842.
DOI: 10.1007/s11060-024-04667-6.
Targeting DCAF5 suppresses SMARCB1-mutant cancer by stabilizing SWI/SNF.
Radko-Juettner S, Yue H, Myers J, Carter R, Robertson A, Mittal P
Nature. 2024; 628(8007):442-449.
PMID: 38538798
PMC: 11184678.
DOI: 10.1038/s41586-024-07250-1.
Super-Enhancer Dysregulation in Rhabdoid Tumor Cells Is Regulated by the SWI/SNF ATPase BRG1.
Jones C, Wang J, Evans J, Sisk H, Womack C, Liu Q
Cancers (Basel). 2024; 16(5).
PMID: 38473277
PMC: 10931202.
DOI: 10.3390/cancers16050916.
Epigenetic regulation in cancer.
Gu M, Ren B, Fang Y, Ren J, Liu X, Wang X
MedComm (2020). 2024; 5(2):e495.
PMID: 38374872
PMC: 10876210.
DOI: 10.1002/mco2.495.
A Rare Case of Rhabdoid Pancreatic Carcinoma: Prolonged Disease-Free Survival Following Upfront Resection and Adjuvant Chemotherapy.
Land G, Van Haeringen B, Cooper C, Andelkovic V, ORourke T
Cureus. 2024; 15(12):e50145.
PMID: 38186431
PMC: 10771581.
DOI: 10.7759/cureus.50145.
The SWI/SNF Complex: A Frequently Mutated Chromatin Remodeling Complex in Cancer.
Nguyen V, Tessema M, Weissman B
Cancer Treat Res. 2023; 190:211-244.
PMID: 38113003
DOI: 10.1007/978-3-031-45654-1_7.
Extradural malignant rhabdoid tumor of the spine in children: A case-based review.
Vigneul E, Rooijakkers H, Joris V, Daoud L, Van Damme A, Raftopoulos C
Childs Nerv Syst. 2023; 40(4):979-986.
PMID: 37995013
DOI: 10.1007/s00381-023-06224-4.